Table 2.
Charlson Comorbidity Index for the Control, Tetrahydrocannabinol-Only, and Tetrahydrocannabinol-Opioid–Positive Groups
| Factor | Control n = 252 |
Multidrug N = 47 |
THC Only n = 54 |
P |
| Charlson Comorbidity Index | ||||
| Myocardial Infarction | 8 (3.17%) | 3 (6.38%) | 1 (1.85%) | 0.43 |
| Congestive heart failure | 3 (1.19%) | 0 | 2 (3.7%) | 0.25 |
| Peripheral vascular disease | 14 (5.56%) | 2 (4.26%) | 1 (1.85%) | 0.50 |
| Cerebrovascular accident | 4 (1.59%) | 1 (2.13%) | 0 | 0.61 |
| Dementia | 10 (3.97%) | 4 (8.51%) | 1 (1.85%) | 0.23 |
| Chronic obstructive pulmonary disease | 17 (6.75%) | 8 (17.02%) | 4 (7.41%) | 0.06 |
| Connective tissue disorder | 4 (1.59%) | 0 | 0 | 0.44 |
| Peptic ulcer | 89 (35.32%) | 21 (44.68%) | 18 (33.33%) | 0.42 |
| Liver disease | 2 (0.79%) | 0 | 0 | 0.67 |
| Diabetes mellitus | 48 (19.05%) | 8 (17.02%) | 7 (12.96%) | 0.56 |
| Hemiplegia | 1 (0.40%) | 0 | 0 | 0.82 |
| Chronic kidney disease | 4 (1.59%) | 2 (4.26%) | 0 | 0.25 |
| Solid tumor | 1 (0.40%) | 4 (8.51%) | 2 (3.7%) | <0.001 |
| Leukemia | 0 | 0 | 0 | |
| Lymphoma | 0 | 0 | 0 | |
| AIDS | 0 | 0 | 0 |
THC = tetrahydrocannabinol